Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
clinical trials
europe blog main
europe top stories
4
×
fda
4
×
life sciences
national blog main
national top stories
allergan
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biofourmis
cancer
cancer immunotherapy
chronic kidney disease
covid-19
crispr
What
bio
roundup
abbvie’s
acquisitions
ahead
alkermes
announced
antipsychotic
benefits
biofourmis
black
bucks
cancer
caveats
celebrate
ceo
chance
collabs
commonly
companies
continue
corner
covid
daniel
day
days
deal
debut
designed
diamond
diamond’s
drug
effect
favor
fda
forward
gain
gilead
gilead’s
help
Language
unset
Current search:
abbvie
×
fda
×
" europe top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
